Intelligent Bio Solutions Partners with B2i Digital for Outreach
Intelligent Bio Solutions Inc. (NASDAQ: INBS), a pioneer in medical technology, is excited to announce a new partnership with B2i Digital aimed at boosting its investor outreach efforts. This collaboration marks a significant step for the company as it seeks to raise awareness about its innovative, non-invasive drug screening technology that is set to transform the industry.
Strategic Marketing Campaign
The partnership with B2i Digital will enable Intelligent Bio Solutions to launch an impactful marketing campaign specifically designed for investors. This campaign will utilize advanced digital marketing strategies to enhance the visibility of the company’s patented drug screening solutions, which offer a faster, non-invasive alternative compared to traditional drug tests.
CEO's Vision on Market Needs
David Shapiro, CEO of B2i Digital, expressed enthusiasm about the collaboration, stating, “Intelligent Bio Solutions has developed a groundbreaking system that addresses a critical need in industries requiring quick and reliable drug screening.” He highlighted that the company’s Intelligent Fingerprinting Drug Screening System is poised to enter the U.S. market after the anticipated FDA clearance, paving the way for substantial growth opportunities.
Targeted Investor Engagement
B2i Digital will concentrate on leveraging data-driven insights across various digital platforms, targeting investors interested in healthcare technology and innovative market solutions. This strategic focus aims to highlight Intelligent Bio Solutions' unique technology, its leading position in the industry, and its growing revenue trajectory.
Importance of Investor Communication
Harry Simeonidis, President and CEO of Intelligent Bio Solutions, noted the importance of effective communication with investors, especially as the company plans to enter the U.S. market. “Our partnership with B2i Digital is instrumental in connecting with investors who recognize the potential in our unique drug screening approach, particularly in industries that prioritize workplace safety,” Simeonidis explained.
About B2i Digital
B2i Digital is a digital marketing agency that specializes in enhancing the visibility of companies to retail investors, institutional investors, and research analysts. Founded in 2021, the firm employs innovative marketing technologies to craft compelling narratives for its clients, ensuring they reach the right audience based on their sector and market stage.
Strategic Expertise
The company’s founder, David Shapiro, brings valuable experience from his previous role as Chief Marketing Officer at Maxim Group LLC, where he gained insights into investor awareness platforms. This expertise will contribute to the success of the marketing campaigns designed for Intelligent Bio Solutions.
About Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc. is at the forefront of medical technology innovation, delivering effective and rapid non-invasive testing solutions. Its Intelligent Fingerprinting Drug Screening System utilizes fingerprint sweat analysis to screen for drug use, promising a hygienic and cost-efficient alternative for employers in various industries, including construction and logistics.
Impactful Solutions for Safety-Critical Industries
The company's technology can provide immediate results in less than ten minutes, making it a vital tool for sectors where safety is paramount, such as manufacturing and drug rehabilitation. Intelligent Bio Solutions is committed to meeting the needs of its clients by ensuring the highest standards of accuracy and reliability.
Frequently Asked Questions
What is the purpose of the partnership between Intelligent Bio Solutions and B2i Digital?
The partnership aims to enhance investor outreach and raise awareness about Intelligent Bio Solutions' innovative drug screening technology through targeted marketing efforts.
What does the Intelligent Fingerprinting Drug Screening System do?
This system provides a fast, non-invasive method for drug testing by analyzing sweat from fingerprints, making it suitable for safety-compliant workplaces.
When is Intelligent Bio Solutions planning to enter the U.S. market?
The company is preparing for U.S. market entry following anticipated FDA approval, expected in the near future.
What industries can benefit from the drug screening technology?
Industries such as construction, manufacturing, drug treatment organizations, and logistics can benefit from this innovative testing solution.
Who can be contacted for more information about the company?
For inquiries, individuals can reach out to Intelligent Bio Solutions via email at info@ibs.inc.
